Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.05.2022 | Case report

β2-adrenergic receptor agonists/corticosteroid/montelukast

Treatment failure: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Eldaabossi SAM, et al. Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital. Respiratory Medicine Case Reports 34: 1 Oct 2021. Available from: URL: http://doi.org/10.1016/j.rmcr.2021.101520 Eldaabossi SAM, et al. Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital. Respiratory Medicine Case Reports 34: 1 Oct 2021. Available from: URL: http://​doi.​org/​10.​1016/​j.​rmcr.​2021.​101520
Metadaten
Titel
β2-adrenergic receptor agonists/corticosteroid/montelukast
Treatment failure: 2 case reports
Publikationsdatum
01.05.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-14904-9

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Anakinra

Case report

Alcohol

Case report

Multiple drugs

Case report

Dexamethasone